NgenBio Finds Answers to Infant Growth Retardation and Obesity in Gut Microbiome

NGS (Next-Generation Sequencing) precision diagnostic platform specialist Ngenbio (CEO Choi Dae-chul) announced on the 3rd that it has registered a patent for a method that provides customized solutions related to infant growth using the gut microbiome. This patented technology can reduce growth retardation or obesity in infants and promote proper growth.

Ngenbio plans to launch a gut microbiome service that provides information on infant growth and temperament using this patented technology in the second half of this year. Based on the accumulated microbiome data and analysis technology for Koreans of various ages, the company intends to identify infant growth and temperament types and provide necessary information for growth. It can also send recommended customized nutrients and daily missions to user devices to promote infant development.

The gut microbiome of infants plays a very important role in growth development, immune system, and mental health. In particular, the composition of the gut microbiome environment during infancy determines the maturity of the immune system and further has a significant impact on adult health. Therefore, monitoring and managing the gut microbiome from infancy lays the foundation not only for a healthy gut environment but also for a healthy life.

Choi Dae-chul, CEO of Ngenbio, said, “Through this patent, it is possible to accurately provide customized recommended activities and nutrients by predicting infant growth and temperament,” and added, “It is expected that tests for infant growth and temperament analysis methods will advance further in the future.”

Meanwhile, on the 17th of last month, Ngenbio signed a business agreement with Mobile Doctor, which operates the healthcare service app ‘Yeolnayo,’ and is exclusively providing infant microbiome testing services. Additionally, Ngenbio is currently conducting joint research on infant oral and gut microbiomes with Seoul National University College of Public Health and Our Children’s Hospital. In the future, Ngenbio plans to expand a network connecting companies, universities, research institutes, and hospitals to raise awareness of the importance of the microbiome environment formed during infancy and to take the lead in providing oral and gut testing services that allow guardians to easily monitor and manage it.

This content was produced with the assistance of AI translation services.